CA52386/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2001	2
2002	8
2003	5
2004	1
2006	2
2012	1
2024	0

1

Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients.

Berenson JR, Crowley JJ, Grogan TM, Zangmeister J, Briggs AD, Mills GM, Barlogie B, Salmon SE. Berenson JR, et al. Blood. 2002 May 1;99(9):3163-8. doi: 10.1182/blood.v99.9.3163. Blood. 2002. PMID: 11964279 Free article. Clinical Trial.

2

High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.

Talbot SM, Rankin C, Taub RN, Balcerzak SP Jr, Bhoopalam N, Chapman RA, Baker LH, Middleman EL, Antman KH. Talbot SM, et al. Cancer. 2003 Jul 15;98(2):331-6. doi: 10.1002/cncr.11512. Cancer. 2003. PMID: 12872353 Free article. Clinical Trial.

3

Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504.

Gandara DR, Chansky K, Albain KS, Leigh BR, Gaspar LE, Lara PN Jr, Burris H, Gumerlock P, Kuebler JP, Bearden JD 3rd, Crowley J, Livingston R; Southwest Oncology Group. Gandara DR, et al. J Clin Oncol. 2003 May 15;21(10):2004-10. doi: 10.1200/JCO.2003.04.197. J Clin Oncol. 2003. PMID: 12743155 Clinical Trial.

4

Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study.

Urba SG, Chansky K, VanVeldhuizen PJ, Pluenneke RE, Benedetti JK, Macdonald JS, Abbruzzese JL; Southwest Oncology Group Study. Urba SG, et al. Invest New Drugs. 2004 Jan;22(1):91-7. doi: 10.1023/b:drug.0000006179.20974.af. Invest New Drugs. 2004. PMID: 14707499 Free article. Clinical Trial.

5

Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome.

Sosman JA, Unger JM, Liu PY, Flaherty LE, Park MS, Kempf RA, Thompson JA, Terasaki PI, Sondak VK; Southwest Oncology Group. Sosman JA, et al. J Clin Oncol. 2002 Apr 15;20(8):2067-75. doi: 10.1200/JCO.2002.08.072. J Clin Oncol. 2002. PMID: 11956267 Clinical Trial.

6

Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).

Gandara DR, Chansky K, Albain KS, Gaspar LE, Lara PN Jr, Kelly K, Crowley J, Livingston R. Gandara DR, et al. Clin Lung Cancer. 2006 Sep;8(2):116-21. doi: 10.3816/CLC.2006.n.039. Clin Lung Cancer. 2006. PMID: 17026812 Clinical Trial.

7

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.

Anderson JE, Kopecky KJ, Willman CL, Head D, O'Donnell MR, Luthardt FW, Norwood TH, Chen IM, Balcerzak SP, Johnson DB, Appelbaum FR. Anderson JE, et al. Blood. 2002 Dec 1;100(12):3869-76. doi: 10.1182/blood-2001-12-0354. Epub 2002 Aug 1. Blood. 2002. PMID: 12393614 Free article. Clinical Trial.

8

Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.

Kelly K, Lovato L, Bunn PA Jr, Livingston RB, Zangmeister J, Taylor SA, Roychowdhury D, Crowley JJ, Gandara DR; Southwest Oncology Group. Kelly K, et al. Clin Cancer Res. 2001 Aug;7(8):2325-9. Clin Cancer Res. 2001. PMID: 11489808 Clinical Trial.

9

Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study.

Rothenberg ML, Benedetti JK, Macdonald JS, Seay TE, Neubauer MA, George CS, Tanaka MS Jr, Giguere JK, Pruitt BT, Abbruzzese JL. Rothenberg ML, et al. Ann Oncol. 2002 Oct;13(10):1576-82. doi: 10.1093/annonc/mdf274. Ann Oncol. 2002. PMID: 12377645 Free article. Clinical Trial.

10

Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial.

Rothenberg ML, Liu PY, Braly PS, Wilczynski SP, Hannigan EV, Wadler S, Stuart G, Jiang C, Markman M, Alberts DS. Rothenberg ML, et al. J Clin Oncol. 2003 Apr 1;21(7):1313-9. doi: 10.1200/JCO.2003.07.031. J Clin Oncol. 2003. PMID: 12663720 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year